76144-82-6 Usage
Uses
Used in Pharmaceutical Industry:
Hydrazinium, 2-(3-methoxy-3-oxopropyl)-1,1,1-trimethyl, chloride (1:1) is used as a reagent in the synthesis of pharmaceuticals for its ability to facilitate the formation of desired chemical compounds.
Used in Agrochemical Industry:
In the agrochemical industry, Hydrazinium, 2-(3-methoxy-3-oxopropyl)-1,1,1-trimethyl, chloride (1:1) is utilized as a reagent in the preparation of agrochemicals, contributing to the development of effective products for agricultural applications.
Used in Cosmetics Industry:
Hydrazinium, 2-(3-methoxy-3-oxopropyl)-1,1,1-trimethyl, chloride (1:1) may have potential applications in the cosmetics industry, where it can be used as a component in the formulation of cosmetic products due to its unique chemical properties.
Used in Materials Science:
Hydrazinium,2-(3-methoxy-3-oxopropyl)-1,1,1-trimethyl-, chloride (1:1) also holds potential in the field of materials science, where it can be employed in the development of new materials with specific properties,得益于其独特的化学结构和反应性.
Check Digit Verification of cas no
The CAS Registry Mumber 76144-82-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,1,4 and 4 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 76144-82:
(7*7)+(6*6)+(5*1)+(4*4)+(3*4)+(2*8)+(1*2)=136
136 % 10 = 6
So 76144-82-6 is a valid CAS Registry Number.
76144-82-6Relevant academic research and scientific papers
Preparation method for high-purity 3-(2,2,2-trimethylhydrazine)methyl propionate crude drug intermediate
-
Paragraph 0012; 0014; 0018-0019, (2019/03/08)
The invention discloses a preparation method for a high-purity 3-(2,2,2-trimethylhydrazine)methyl propionate crude drug intermediate. The intermediate is an important medical intermediate of mildronate and aziridine anti-cancer drugs. A conventional method is that 1,1-dimethylhydrazine reacts with methyl acrylate, and vacuum distillation is performed and a methylation reaction is performed to obtain a target product. The intermediate obtained by this type of the reaction contains ammonium salt related impurities so that the variety and content of final crude drug impurities exceed an impuritylimited field of European Pharmacopoeia, and a purifying technology is complicated. The invention provides an efficient improved method for preparing the two types of the compounds. A high-purity product can be obtained and a productive rate of the product is improved, cost is reduced, and industrial large-scale production is realized.
